Study to Evaluate the Safety and Immunogenicity of Travel Vaccines when Administered Concomitantly with Meningococcal ACWY Conjugate Vaccine in Healthy Adults

Update Il y a 4 ans
Reference: EUCTR2011-000475-14

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary Africa/Latam Traveler Scheme  To establish the non-inferiority of typhoid Vi polysaccharide and yellow fever vaccines given concomitantly with MenACWY-CRM to typhoid Vi polysaccharide and yellow fever vaccines given alone, as measured by geometric mean titers/concentrations (GMTs/GMCs) to typhoid and yellow fever, 28 days after vaccine administration (Group 2 vs.1). Asia Traveler Scheme  To establish the non-inferiority of Japanese encephalitis and rabies virus vaccines given concomitantly with MenACWY-CRM to Japanese encephalitis and rabies virus vaccines given alone, as measured by GMTs to Japanese encephalitis 28 days after administration of the 2nd dose of Japanese encephalitis vaccine and by GMCs to rabies 28 days after administration of the 3rd dose of rabies virus vaccine (Group 5 vs. 4).


Inclusion criteria

  • Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines when Administered Concomitantly with Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Adults